Drug Product
Company Overview
About
C2 PHARMA is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:India
Founded:2016
Employees:1,368
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval WLWX56
EMA · #APR-PEIT7QBG · 2021-04-01
Drug Approval E3QRP0
EMA · #APR-H9MJ4Z75 · 2021-03-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-DO32F4MC
Issued: 2020-09-10
Expires: 2025-01-25
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-7VORMAPR
Issued: 2020-06-17
Expires: 2025-12-25
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-HFXMD2DT
Issued: 2020-04-27
Expires: 2025-04-19
Health Canada GMP
Health Canada
Cert #: CERT-9BDP4N50
Issued: 2020-05-08
Expires: 2025-04-07
Loading CDMO intelligence...
Key facts about C2 PHARMA
- C2 PHARMA is headquartered in India.
- C2 PHARMA was founded in 2016.
- C2 PHARMA has 1,368 employees.
- C2 PHARMA's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like C2 PHARMA
Directory pages this company appears in, each with the full list of matching manufacturers.